On ECHEMI
Home > Drugs > Nintedanib esylate Registered Holders
Nintedanib esylate structure

Nintedanib esylate structure

Nintedanib esylate

Nintedanib esylate (BIBF 1120 esylate) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.

Find 35 Related Holders

CSPC OUYI Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2001-03-29
  • Country:

    China China
  • Address:

    No. 88, Yangzi Road, Shijiazhuang Economic and Technological Development Zone
  • Tax NO.:

    91130100601289268L
  • Registered Funds:

    298 million yuan
  • Website:

  • Email:

Sichuan Kelun Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2002-05-29
  • Country:

    China China
  • Address:

    South 2nd Road, Xindu Satellite City Industrial Development Zone, Chengdu
  • Tax NO.:

    9151010020260067X4
  • Registered Funds:

    1,601,497,373 yuan
  • Website:

  • Email:

SICHUAN KELUN PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
FORMOSA LABORATORIES INC
United States United States

API Registration Country

API Active
영진약품(주)
South Korea South Korea

API Registration Country

API Active
한국바이오켐제약(주)
South Korea South Korea

API Registration Country

API Active
Hetero Labs Limited Unit-I
South Korea South Korea

API Registration Country

API Active
Sun Pharmaceutical Industries Ltd
United States United States

API Registration Country

API Active
CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
BDR LIFESCIENCES PRIVATE LTD
United States United States

API Registration Country

API Active
Recommended Suppliers of Nintedanib esylate
View 41 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.